Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2002
04/04/2002WO2002026815A2 Identification of neuroblastoma tumor suppressor genes
04/04/2002WO2002026814A1 A novel peptide---human protein 8.8 including 4 peptide repeat sequences and the polynucleotide coding this novel peptide
04/04/2002WO2002026813A1 A novel peptide - human muscle cell enhanced associative factor 222.88 and the polynucleotide coding this novel peptide
04/04/2002WO2002026812A1 A novel peptide---human dna cgg repeated associative protein 16.17 and the polynucleotide coding this novel peptide
04/04/2002WO2002026811A1 A novel peptide---symplekin 8,91 and the polynucleotide coding this novel peptide
04/04/2002WO2002026810A1 A novel polypeptide - protein p125-77.22 and a polynucleotide encoding the same
04/04/2002WO2002026809A1 A new polypeptide- transmembrane 35.31 containing epidermal growth factor-like repeating domain and the polynucleotide encoding it
04/04/2002WO2002026808A1 A novel polypeptide - human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same
04/04/2002WO2002026807A1 A novel peptide---human krupple zinc finger related protein 70.84 and the polynucleotide coding this novel peptide
04/04/2002WO2002026806A1 A novel peptide-human myosin heavy chain b22.22 and the polynucleotide coding this novel peptide
04/04/2002WO2002026805A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/04/2002WO2002026804A2 84241, a human ring finger family member and uses thereof
04/04/2002WO2002026802A2 M32404, a novel human trypsin and uses thereof
04/04/2002WO2002026801A2 Secreted proteins and their uses
04/04/2002WO2002026799A1 A novel polypeptide -human cytoplasmic dynein intermediated chain (ic) 9.35 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026798A1 A novel polypeptide -phosphatidic acid phosphatase 29.81 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026797A1 A novel polypeptide -human dehydrogenase 29.15 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026796A1 A novel polypeptide human growth factor receptor 14.3 and the polynucleotide encoding said polypeptide
04/04/2002WO2002026795A1 A novel polypeptide, a human dihydroorotase 15.29 and the polynucleotide encoding the polypeptide
04/04/2002WO2002026794A1 A novel polypeptide, a human ribosomal protein l7a20.57 and the polynucleotide encoding the polypeptide
04/04/2002WO2002026793A1 A novel polypeptide-homo macro-protein 62 and polynucleotide encoding said polypeptide
04/04/2002WO2002026792A1 A novel polypeptide, a human big protein 9.24 and the polynucleotide encoding the polypeptide
04/04/2002WO2002026791A1 A novel polypeptide-sr protein specificity serine kinase 212.98 and polynucleotide encoding said polypeptide
04/04/2002WO2002026790A1 A novel polypeptide-homo tnfr/ngfr protein 9.02 containing cytochrome c structural domain and polynucleotide encoding said polypeptide
04/04/2002WO2002026789A2 Nucleotide sequences mediating male fertility and method of using same
04/04/2002WO2002026785A2 Epitopes of virus hepatitis c specifically cd4+ t lymphocytes
04/04/2002WO2002026784A2 Matrix proteins m1 and m2 of infections salmon anaemia virus
04/04/2002WO2002026780A2 Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
04/04/2002WO2002026779A2 A fibrin/fibrinogen-binding conjugate
04/04/2002WO2002026778A2 Isolated peptides which bind to hla-c molecules and uses thereof
04/04/2002WO2002026758A1 Oligonucleotide modulation of her-1 expression
04/04/2002WO2002026757A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
04/04/2002WO2002026755A2 Nucleotide sequences which code for the ppgk gene
04/04/2002WO2002026754A2 Oligonucleotides, agents containing these oligonucleotides, and the use thereof
04/04/2002WO2002026376A2 High density arrays
04/04/2002WO2002026250A2 Vaccines for proliferative ileitis
04/04/2002WO2002026209A2 Microparticles for delivery of the heterologous nucleic acids
04/04/2002WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
04/04/2002WO2002026192A2 Viruses targeted to hypoxic cells and tissues
04/04/2002WO2002026107A2 Model for neurodegenerative diseases involving amyloid accumulation
04/04/2002WO2002026028A2 Characterization of phenylalanine ammonia-lyase (pal) gene in wounded lettuce
04/04/2002WO2002018621A8 Glut10: a novel glucose transporter in the type 2 diabetes linked region of chromosome 20q12-13.1
04/04/2002WO2002016558A9 Methods for imparting desirable phenotypic traits, including drought, freeze, and high salt tolerance and methods for increasing seed production
04/04/2002WO2002010339A3 Gene expression profile for kshv infection and methods for treating same
04/04/2002WO2002008435A8 Codon-optimized papilloma virus sequences
04/04/2002WO2002004636A8 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS
04/04/2002WO2002002741A3 Methods for genetic interpretation and prediction of phenotype
04/04/2002WO2002000251A9 Vaccine against foot-and-mouth disease
04/04/2002WO2001098487A8 Polynucleotides and polypeptides linked to blood pressure regulation and/or fatigue
04/04/2002WO2001094610A3 Binary hybrid mutational vectors
04/04/2002WO2001094544A3 N.bstnbi nicking endonuclease and methods for using endonucleases in single-stranded displacement amplification
04/04/2002WO2001092468A3 Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
04/04/2002WO2001090306A3 Compositions and methods for modulating tumor specific expression
04/04/2002WO2001088532A3 Improved assay techniques using nematode worms
04/04/2002WO2001088185A3 A filter element for use in separation of biomaterials from solid contaminants
04/04/2002WO2001088155A3 33428, a human metalloprotease family member and uses thereof
04/04/2002WO2001088106A3 Novel deoxyribonucleside kinase enzyme multi-substrate variants
04/04/2002WO2001085980A3 Enzymatic assays for screening anti-cancer agents
04/04/2002WO2001085921A3 Human serine-threonine kinase-4
04/04/2002WO2001085784A3 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
04/04/2002WO2001085100A3 Vasodilator-thrombolytic fusion proteins and conjugates
04/04/2002WO2001083767A3 Nucleotide sequences coding for the cls gene
04/04/2002WO2001083765A3 Nucleotides sequences coding for the cdsa gene
04/04/2002WO2001083764A3 Nucleotide sequences which code for the cma gene
04/04/2002WO2001083762A3 26343, a novel human oxidoreductase and uses therefor
04/04/2002WO2001081588A3 2246, novel protein kinase molecules and uses therefor
04/04/2002WO2001079462A3 Nucleic acids encoding polypeptides having haloperoxidase activity
04/04/2002WO2001078896A3 Purification apparatus and method
04/04/2002WO2001077294A3 Hpv-specific short-mers
04/04/2002WO2001075452A3 Detection of nerve damage using marker scip
04/04/2002WO2001075128A3 Method for the production of leguminous plants with increased protein content and longer seed filling duration
04/04/2002WO2001075067A3 Novel nucleic acids and polypeptides
04/04/2002WO2001073084A3 Methods for rapidly producing transgenic monocotyledonous plants
04/04/2002WO2001073060A3 18221, dual specificity phosphatase and uses thereof
04/04/2002WO2001073051A3 46743 and 27417, novel human acyltransferase family members and uses therefor
04/04/2002WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer
04/04/2002WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
04/04/2002WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
04/04/2002WO2001072839A3 Human g-protein coupled receptors
04/04/2002WO2001072829A3 Peptides blocking vascular endothelial growth factor (vegf)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
04/04/2002WO2001072781A3 Human genes and expression products
04/04/2002WO2001071022A3 Lpa receptor agonists and antagonists and methods of use
04/04/2002WO2001071017A3 Modified nodavirus rna for gene delivery
04/04/2002WO2001070988A3 Receptors for hypersensitive response elicitors and uses thereof
04/04/2002WO2001070948A3 Methods and compositions for elucidating protein expression profiles in cells
04/04/2002WO2001070942A3 Transformed plant having heterologous glucan branching enzyme activity
04/04/2002WO2001070386A3 Polyfunctional support material for complex nucleic acid analysis
04/04/2002WO2001068837A3 Antisense oligonucleotides of the human chk1 gene and uses thereof
04/04/2002WO2001068821A3 Novel subtilase enzymes having an improved wash performance on egg stains
04/04/2002WO2001068695A3 Factor-h related protein 5 (fhr-5) and antibodies thereto
04/04/2002WO2001068674A3 Preparation of recombinant proteins containing repeating units
04/04/2002WO2001068255A3 Microarray spotting instruments incorporating sensors
04/04/2002WO2001066741A3 Kcnb: a novel potassium channel protein
04/04/2002WO2001066566A3 Rotavirus pseudoviral particles and use thereof for vectorizing proteins or nucleic acids
04/04/2002WO2001064896A3 Human enzyme molecules
04/04/2002WO2001062778A3 Tumour-specific animal proteins
04/04/2002WO2001059113A3 G-protein coupled receptor proteins and nucleic acids encoding same
04/04/2002WO2001058494A3 Gene therapy for treating ocular-related disorders
04/04/2002WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
04/04/2002WO2001054813A3 Devices and methods for biochip multiplexing